Neurocrine Biosciences Inc. (NBIX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
51.42-1.94 (-3.64%)
At close: 4:00 PM EDT
People also watch:
ALKSLGNDPGNXNKTRINCY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open53.37
Prev Close53.36
Bid0.00 x
Ask54.00 x 500
Day's Range50.42 - 53.54
52wk Range31.25 - 58.46
1y Target EstN/A
Market Cap4.46B
P/E Ratio (ttm)-36.01
Beta0.05
Volume749,659
Avg Vol (3m)747,735
Dividend & Yield0.00 (0.00%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Blue Jay Capital Betting On Big Returns From These Healthcare Stocks
    Insider Monkey7 days ago

    Blue Jay Capital Betting On Big Returns From These Healthcare Stocks

    Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California. Prior to founding Blue Jay Capital (named after Canada’s only current Major League Baseball team, the Toronto Blue Jays), Mr. Sinclair founded and ran another healthcare-focused hedge fund Expo Capital Management (named after the former Canadian MLB team the Montreal […]

  • PR Newswire21 days ago

    Neurocrine Biosciences to Present at the Morgan Stanley Global Healthcare Conference

    SAN DIEGO, Sept. 7, 2016 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting at the Morgan Stanley Healthcare Conference in New York City. Listeners are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month. Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders.

  • PR Newswire27 days ago

    Neurocrine Biosciences to Present at the Baird 2016 Healthcare Conference

    SAN DIEGO, Sept. 1, 2016 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting at the Baird 2016 Healthcare Conference in New York City. Listeners are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.